Voyageur Pharmaceuticals Ltd.
VM.V
TSX
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -951.20K | -387.10K | -571.30K | -333.30K | -261.00K |
| Total Depreciation and Amortization | 200.00 | 200.00 | 200.00 | 300.00 | 300.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 172.40K | 202.80K | 282.70K | 60.20K | 52.50K |
| Change in Net Operating Assets | 134.70K | -1.30K | -675.10K | 331.80K | 236.80K |
| Cash from Operations | -643.90K | -185.40K | -963.50K | 59.00K | 28.60K |
| Capital Expenditure | -83.90K | -14.60K | -29.60K | -25.70K | -40.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -83.90K | -14.60K | -29.60K | -25.70K | -40.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.63M | 90.20K | 1.61M | 0.00 | 5.60K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -68.70K | -69.50K | 283.90K | 116.70K | 0.00 |
| Cash from Financing | 1.14M | 14.70K | 1.32M | 84.80K | 4.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | -- | -- |
| Net Change in Cash | 411.70K | -185.30K | 330.80K | 118.10K | -7.40K |